rediff News http://www.rediff.com/tags/lymphocyte+count India's largest news and entertainment service online.. en-us Sat, 03 Dec 16 09:44:12 +0000 Sat, 03 Dec 16 09:44:12 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Rape victim better, is optimistic about her future: Docs]]> http://www.rediff.com/news/report/rape-victim-better-is-optimistic-about-her-future-docs/20121222.htm Sat, 03 Dec 2016 15:14:12 +0530 <![CDATA[ The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Biogen..]]> http://in.advfn.com/news_BIIB-INVESTOR-ALERT-The-Law-Offices-of-Vincent-Wo_73030712.html Sat, 03 Dec 2016 15:14:12 +0530 <![CDATA[CTI BioPharma Announces Phase 3 Data from the PERSIST-2 Trial of Pacritinib to be Presented in Late-Breaking..]]> http://in.advfn.com/news_CTI-BioPharma-Announces-Phase-3-Data-from-the-PERS_72966036.html Sat, 03 Dec 2016 15:14:12 +0530 <![CDATA[ Levi & Korsinsky, LLP Reminds Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2016 BIIB]]> http://www.bizwireexpress.com/showstoryGNW.php?storyid=144130 Sat, 03 Dec 2016 15:14:12 +0530 <![CDATA[Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Mature T-...]]> http://businesswireindia.com/news/news-details/seattle-genetics-takeda-complete-enrollment-phase-3-echelon-2-clinical-trial-evaluating-adcetris-brentuximab-vedotin-frontline-mature-t-cell-lymphoma/50923 Sat, 03 Dec 2016 15:14:12 +0530 <![CDATA[Lion Biotechnologies Presents Encouraging TIL Technology Data in Four Posters at 2016 SITC Annual Meeting]]> http://in.sys-con.com/node/3949339 Sat, 03 Dec 2016 15:14:12 +0530